Navigation Links
Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP
Date:10/22/2008

somnia and a history of prolonged middle of the night awakenings. Subjects were randomized to receive 1.75 mg or 3.5 mg doses of Intermezzo(R), or a placebo, over three 2-night treatment periods.

The study results demonstrated that Intermezzo(R) 1.75 mg and 3.5 mg doses, when taken at the time of a middle of the night awakening, significantly shortened the time for patients to return to sleep as compared to placebo and there was no evidence of next morning residual effects. Patients taking Intermezzo(R) 3.5 mg also had statistically significant improvements in post-dose total sleep time, sleep efficiency, subjective number of awakenings and sleep quality. Morning questionnaires also revealed improvements in the level of refreshed sleep and next day ability to function compared to placebo.

Dr. Roth commented, "This study supports the safety and efficacy of Intermezzo(R) for the treatment of middle of the night awakenings at the time they occur. The most commonly prescribed sleep medications are intended to be taken at bedtime and they produce sleep for seven to eight hours after dosing. Such medications can be used at bedtime to prevent an awakening later in the night, but the patient must either anticipate which nights an awakening may occur, or take a seven to eight hour sleep aid every night. The results of this study suggest that low dose sublingual zolpidem (Intermezzo(R)) may offer patients a fast acting low-dose alternative that can be taken only when it is really needed at the time of an awakening, and which provides rapid return to sleep without the risk of residual sedation the following morning."

Glenn A. Oclassen, President and Chief Executive Officer of Transcept, remarked, "We congratulate Dr. Roth and his colleagues on the publication in SLEEP. Along with our Phase 3 outpatient study, Dr. Roth's sleep-lab study serves as the foundation for the Intermezzo(R) New Drug Application we recently submitted to the U.S. Food and Drug Admini
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
6. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
9. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
10. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... The American Filtration and Separations Society will hold its 23rd Annual ... Hyatt Hotel in San Antonio, Texas. To further impact the separation ... we are proud to announce that the 2010 AFS Annual Technical ... , , ... Minneapolis, MN (PRWEB) December 16, 2009 ...
(Date:12/15/2009)... 15 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China ... CSKI ), a,leading fully integrated pharmaceutical company developing ... China ("PRC"), today,announced that the Company has 30 ... of the National Basic Medical Insurance, Industrial Injury ... The 30 medicines treat a variety ...
(Date:12/15/2009)... (AFM) have been developed and are opening up a new ... The NeedleProbes’ cylindrical geometry enables researchers to measure surface tension, ... in a single force distance curve. , ... ... NeedleProbes are enabling unique measurements at the liquid/air ...
(Date:12/15/2009)... MANOR, N.Y., Dec. 15 On January ... International Society for Medical Publication Professionals (ISMPP) will ... in London, UK. More than 100 attendees are ... forum for publication professionals, editors, publishers, medical writers ... of medical publications and the impact of guidelines ...
Breaking Biology Technology:American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2
... clients, success in managed care, GLADSTONE, N.J., ... market agency focused on securing formulary access for,today,s ... RPh,as Managing Partner. Renick will provide strategic counsel ... GlaxoSmithKline,sanofi-aventis, and Forest Laboratories., "Dan brings a ...
... LONG BRANCH, N.J., May 28 To date, ... from around the world are scheduled,to exhibit at ... in New Jersey., The conference and exhibition ... than last September. The supplier community is attracted ...
... plc (AIM:,PRG), the international pharmaceutical services group, announces ... and Global Head,of Medical Management and Safety. In ... Management and Safety team ensuring the delivery of,quality ... to Premier Research a wealth of experience in,global ...
Other Biology Technology:Dan Renick, RPh, Joins The Hobart Group as Managing Partner 260 Specialty Chemical, Fine Chemical & Custom Synthesis Providers Will Exhibit at Pharma ChemOutsourcing on September 8-9 in New Jersey 2Premier Research Names Anthony Faragasso, MD as Executive Director and Global Head of Medical Management and Safety 2
(Date:12/16/2009)... short-term, seasonal exposure to pesticides in rivers and ... wild salmon populations. In addition to the widespread ... exposure to commonly used pesticides may further inhibit ... , "Major efforts are currently underway to restore ... depressed populations," says David Baldwin of the National ...
(Date:12/16/2009)... Dec. 1 iQor, a global provider of ... 2009 InfoWorld 100 Awards Top 100 IT ... This was the first submission for iQor. ,, "We ... of companies," said Vikas Kapoor, president and CEO of ... business, allowing us to work faster, smarter and with ...
(Date:12/16/2009)... 3 BIO-key International, Inc. (OTC ... public safety and finger-based biometric identification solutions, ... at a Special Shareholder Meeting held today ... Enforcement Division to Interact911 Mobile Systems Inc. ... in favor and 1.2% were opposed. ,, ...
Breaking Biology News(10 mins):Even at sublethal levels, pesticides may slow the recovery of wild salmon populations 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Leading Anti Abortion Group Vows to Vigorously Fight the Senate Health Bill 61881 1Leading Anti Abortion Group Vows to Vigorously Fight the Senate Health Bill 61881 2AARP Hosts Rep Bill Foster In Health Care Reform Forum 61878 1AARP Hosts Rep Bill Foster In Health Care Reform Forum 61878 2Medelita Introduces Men 26apos 3Bs Lab Coat Collection 61875 1Medelita Introduces Men 26apos 3Bs Lab Coat Collection 61875 2Medelita Introduces Men 26apos 3Bs Lab Coat Collection 61875 3
... University of Sheffield and Queen Mary, University of London, ... by sunlight when they are faced with extreme climates. ... could have implications both for adapting plants to the ... harness solar energy. , Photosynthesis in plants relies ...
... distribution models are often cited as being important for ... change and informing managers on management options for land ... of spatial dependency, meaning that points closer together in ... those further apart, a fact which may critically bias ...
... study Quaternary climate changes explain diversity among reptiles and ... life on Earth not evenly distributed? Geographic patterns of ... for centuries, and continue to spur scientific debate. Studies ... to the conclusion that species diversity is best predicted ...
Other Biology News:Scientists unravel plants' natural defenses 2Are current projections of climate change-impacts on biodiversity misleading? 2Are current projections of climate change-impacts on biodiversity misleading? 3
General description: MaxiSorp TM surface is ideal for arraying molecules with mixed hydrophilic/hydrophobic domains such as proteins ID clarifier: Maxisorp(tm) with lid...
... for fully automated systems for a broad ... configured for applications ranging from compound logistics, ... loop screening, which means it has fully ... picking and follow up studies all at ...
... over 20 years of experience in providing ... Sciences, the Freedom EVO platform delivers even ... to future needs. Together with the new ... equipped to successfully operate genomics, proteomics, and ...
... Systems provide fast and reliable automation ... and drug development laboratories. Staccato Custom ... specifications, providing solutions that are tailored ... Custom Systems are controlled with either ...
Biology Products: